|
1
|
Central pulse pressure and mortality in end-stage renal disease.
|
Hypertension
|
2002
|
3.02
|
|
2
|
Arterial stiffness and kidney function.
|
Hypertension
|
2004
|
2.45
|
|
3
|
Aortic pulse wave velocity index and mortality in end-stage renal disease.
|
Kidney Int
|
2003
|
2.21
|
|
4
|
Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure.
|
J Am Soc Nephrol
|
2005
|
2.20
|
|
5
|
Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients.
|
Hypertension
|
2005
|
2.08
|
|
6
|
Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease.
|
Circulation
|
2002
|
1.58
|
|
7
|
Arterial stiffness and pulse pressure in CKD and ESRD.
|
Kidney Int
|
2012
|
1.38
|
|
8
|
Assessment and significance of arterial stiffness in patients with chronic kidney disease.
|
Curr Opin Nephrol Hypertens
|
2008
|
1.20
|
|
9
|
Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference.
|
Kidney Int
|
2009
|
1.16
|
|
10
|
Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients.
|
Am J Kidney Dis
|
2005
|
1.15
|
|
11
|
In vivo shear stress determines circulating levels of endothelial microparticles in end-stage renal disease.
|
Hypertension
|
2007
|
1.12
|
|
12
|
Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study.
|
Nephrol Dial Transplant
|
2011
|
1.11
|
|
13
|
Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects.
|
J Hypertens
|
2004
|
1.10
|
|
14
|
Prognostic significance of arterial stiffness measurements in end-stage renal disease patients.
|
Curr Opin Nephrol Hypertens
|
2002
|
1.06
|
|
15
|
Local shear stress and brachial artery functions in end-stage renal disease.
|
J Am Soc Nephrol
|
2007
|
1.02
|
|
16
|
Monocyte subpopulations and cardiovascular risk in chronic kidney disease.
|
Nat Rev Nephrol
|
2012
|
1.02
|
|
17
|
Control of mineral metabolism and bone disease in haemodialysis patients: which optimal targets?
|
Nephrol Dial Transplant
|
2012
|
1.02
|
|
18
|
Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis.
|
Nat Rev Nephrol
|
2011
|
1.01
|
|
19
|
Early prediction of IgA nephropathy progression: proteinuria and AOPP are strong prognostic markers.
|
Kidney Int
|
2004
|
0.95
|
|
20
|
Current management of secondary hyperparathyroidism: a multicenter observational study (COSMOS).
|
J Nephrol
|
2008
|
0.95
|
|
21
|
Arterial structure and function in end-stage renal disease.
|
Curr Hypertens Rep
|
2008
|
0.93
|
|
22
|
Modeling the implications of changes in vascular calcification in patients on hemodialysis.
|
Kidney Int
|
2005
|
0.90
|
|
23
|
Cardiovascular disease in the dialysis population: prognostic significance of arterial disorders.
|
Curr Opin Nephrol Hypertens
|
2006
|
0.89
|
|
24
|
Flow-mediated vasodilation in end-stage renal disease.
|
Clin J Am Soc Nephrol
|
2011
|
0.83
|
|
25
|
Bone-vascular axis in chronic kidney disease: a reality?
|
Clin J Am Soc Nephrol
|
2009
|
0.78
|
|
26
|
Renal replacement therapy for heart failure patients: in whom, when and which therapy to use?
|
Nephrol Dial Transplant
|
2009
|
0.75
|
|
27
|
Hypertension and chronic kidney disease: respective contribution of mean and pulse pressure and arterial stiffness.
|
J Hypertens
|
2015
|
0.75
|
|
28
|
Effects of aortic stiffness abnormalities on the heart.
|
Semin Dial
|
2011
|
0.75
|
|
29
|
Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH).
|
J Hypertens
|
2017
|
0.75
|